Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Millipore Opens Bioprocess Facility | Contract Pharma

What are you searching for?

Sign in
Breaking News

Millipore Opens Bioprocess Facility

Millipore Corp. has opened its expanded single-use biomanufacturing facility in Danvers, MA.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Millipore Corp. has opened its expanded single-use biomanufacturing facility in Danvers, MA. The 33,000-sq.-ft. expansion concentrates on producing a wide range of the company’s Mobius single-use technologies, and allows for scale-up when additional manufacturing capacity is needed.

“We’re pleased to mark the completion of this facility because single-use technologies are becoming such an integral part of the biopharmaceutical landscape and our customers’ processes,” said Jean-Paul Mangeolle, president, Bioprocess Division, Millipore. “This expansion demonstrates our ability to stay at the forefront of the industry and our commitment to single-use technologies.”

The bioprocess facility will employ approximately 120 people and contains 12,500 sq. ft. of Class 10,000 cleanroom space, which is in the process of becoming LEED Gold certified.

“Operational flexibility is key as companies turn more and more to single-use technologies. This facility allows us to meet this increasing demand and helps us meet our customers’ needs,” said Paul Chapman, vice president, Downstream Processing, Millipore.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters